Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Research Publications

As featured in the Houston Chronicle, Wall Street Journal, and Forbes

Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.

Ghebremariam YT, Lependu P, Lee JC, Erlanson DA, Slaviero A, Shah NH, Leiper J, Cooke JP.
Circulation. 2013 Aug 20;128(8):845-53. PMID: 23825361

 As featured in the Houston Chronicle

Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation

Deng T, Lyon CJ, Minze LJ, Lin J, Zou J, Liu JZ, Ren Y, Yin Z, Hamilton DJ, Reardon PR, Sherman V, Wang HY, Phillips KJ, Webb P, Wong ST, Wang RF, Hsueh WA.
Houston Methodist Diabetes and Metabolism Institute, Research Institute, Houston, TX 77030, USA.
Cell Metabolism. 2013 Mar 5;17(3):411-22. PMID: 23473035


Recent Publications: